文献速递传染病防控与疫情报告妇幼与学校卫生

刚果民主共和国孕妇作为疟疾基因组监测哨兵人群:一项基于人群的研究

Pregnant women as a sentinel population for genomic surveillance of malaria in the Democratic Republic of the Congo: a population-based study.
PubMed 文献 · Lancet Glob Health · 2025-01-01

该基于人群的研究在刚果民主共和国金沙萨的城市和半农村地区招募4001名孕妇和2794名14岁以下儿童,比较两组恶性疟原虫基因组及耐药突变频率。结果显示两组在各检测位点的等位基因频率高度相似,孕妇磺胺多辛-乙胺嘧啶耐药单倍型频率不高于儿童,未发现高频率kelch13突变。将基因组监测整合入常规产前保健可产生与儿童队列高度相似的抗疟药耐药监测结果。

要点

  • 孕妇与儿童队列的疟原虫种群在所有检测位点等位基因频率高度相似。
  • 孕妇磺胺多辛-乙胺嘧啶耐药单倍型频率不高于儿童,未发现高频率kelch13突变。
  • 孕妇寄生虫密度较低,但感染复杂度与儿童相似。

核心结论

  • 孕妇队列通过整合入常规产前保健活动的简单高效基因组监测系统,产生的抗疟药耐药监测结果与同地区儿童队列高度相似,同时使孕妇获得诊断和治疗。

研究设计与样本

  • 基于人群的研究,在刚果民主共和国金沙萨城市(Binza)和半农村(Maluku)两个疟疾地方性流行且常年传播地区,招募不限年龄、孕周、产次或既往产前保健中心就诊史的孕妇及同一地区14岁以下儿童。
  • 孕妇在常规产前保健就诊时受邀入组;儿童原计划开展标准学校调查,因COVID-19疫情及后续疫苗接种活动影响,改为在现有卫生中心设立筛查点并由社区卫生工作者鼓励家庭自行前往。
  • 对疟疾阳性病例血样采用扩增子测序平台进行基因分型,比较两组恶性疟原虫基因组并估计耐药突变流行率;研究注册号ClinicalTrials.gov NCT05072613。
  • 2021年11月11日至2023年6月21日期间,共招募2794名儿童和4001名孕妇。

主要发现

  • 快速诊断试验疟疾患病率在儿童为49.0%(95%CI 47.1-50.8),在孕妇为19.1%(95%CI 17.9-20.3)。
  • 两组寄生虫种群在所有检测位点(包括可能处于选择压力下的耐药标志物)的等位基因频率高度相似。
  • 孕妇磺胺多辛-乙胺嘧啶耐药单倍型频率不高于儿童,未发现任何kelch13突变达到显著频率。
  • 孕妇寄生虫密度较低,但感染复杂度与儿童相似;研究未发现间日疟原虫感染证据。

临床怎么用

  • 作者认为,将简单高效的基因组监测系统整合入常规产前保健活动,孕妇队列可作为同地区儿童抗疟药耐药监测的哨兵人群,同时使孕妇获得诊断和治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genomic surveillance is a valuable tool for detecting changes in the drug susceptibility of malaria parasites, enabling timely adjustments to treatment strategies. However, implementation can be costly and challenging in high-burden countries, especially when targeting cohorts of children. To address these challenges, we investigated whether in the Democratic Republic of the Congo pregnant women attending antenatal care services could act as an effective sentinel population for children in the same area. METHODS: This population-based study aimed to target pregnant women in Kinshasa (Democratic Republic of the Congo), regardless of age, trimester of pregnancy, parity, or previous antenatal care centre attendance, and children younger than 14 years living in the same area. Women were invited to participate and enrolled during their routine antenatal care visit. For children, we originally planned to conduct standard school-based surveys, but implementation was affected by the COVID-19 pandemic and subsequent vaccination campaign. Therefore, we adopted an alternative approach, setting up screening posts in existing health centres and, with the support of community health workers, encouraging families to visit the posts at their convenience. The study was done in two areas of Kinshasa, urban (Binza) and semirural (Maluku), where malaria transmission is endemic and perennial. Blood samples from malaria-positive cases were genotyped using an amplicon sequencing platform, to allow comparisons of Plasmodium falciparum genomes between the two cohorts and estimations of drug resistance mutation prevalence. The study is registered with ClinicalTrials.gov, NCT05072613. FINDINGS: Between Nov 11, 2021, and June 21, 2023, 2794 children and 4001 pregnant women were recruited to the study. Malaria prevalence by rapid diagnostic test was 49·0% (95% CI 47·1-50·8) in children and 19·1% (17·9-20·3) in pregnant women. Parasite populations sampled from the two cohorts showed highly similar allele frequencies at all tested loci, including drug resistance markers potentially under selection. Pregnant women did not have higher frequencies of sulfadoxine-pyrimethamine resistant haplotypes, which undermine preventive treatments, than children and we did not find any kelch13 mutations at significant frequency. Although parasite densities were lower in pregnant women, the complexity of infection was similar to that in children. We found no evidence of Plasmodium vivax infections in the study. INTERPRETATION: A cohort of pregnant women produced highly similar results for antimalarial drug resistance surveillance as a cohort of children from the same area, through implementation of simple and efficient genomic surveillance systems integrated into routine antenatal care activities, while benefiting women with diagnosis and treatment. FUNDING: Bill & Melinda Gates Foundation and Wellcome Trust.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Onyamboko M, Wasakul V, Bakomba SB, et al. Pregnant women as a sentinel population for genomic surveillance of malaria in the Democratic Republic of the Congo: a population-based study. Lancet Glob Health. 2025. PMID: 40021306. doi:10.1016/S2214-109X(24)00497-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。